Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sutro Biopharma, Inc. (STRO) had Receiveable Turnover of 1.70 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$9.84M |
|
$-38.53M |
|
-- |
|
$9.84M |
|
$39.73M |
|
$-29.89M |
|
$-8.64M |
|
$-38.53M |
|
$-38.53M |
|
$-38.53M |
|
$-38.53M |
|
$-38.53M |
|
$-38.53M |
|
$-29.89M |
|
$-29.08M |
|
16.57M |
|
16.57M |
|
$-2.33 |
|
$-2.33 |
|
| Balance Sheet Financials | |
$175.65M |
|
$8.36M |
|
$18.82M |
|
$194.46M |
|
$52.90M |
|
-- |
|
$244.88M |
|
$297.78M |
|
$-103.32M |
|
$-103.32M |
|
$-103.32M |
|
16.58M |
|
| Cash Flow Statement Financials | |
$-80.55M |
|
$-25.90M |
|
$102.66M |
|
$58.99M |
|
$55.19M |
|
$-3.79M |
|
$3.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-303.77% |
|
-303.77% |
|
-- |
|
-391.63% |
|
-391.64% |
|
$-80.56M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
1.70 |
53.03 |
|
37.30% |
|
37.30% |
|
-19.82% |
|
37.30% |
|
$-6.23 |
|
$-4.86 |
|
$-4.86 |
|